| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 4 Aug 2025 | 30 Jul 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 inter alia to consider and approve the Unaudited Financial Results for the quarter ended 30th June 2025 Board Meeting Outcome for The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2025 Results For The Quarter Ended June 30, 2025. (As Per BSE Announcement Dated on :04.08.2025) | ||
| Board Meeting | 30 May 2025 | 27 May 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the quarter and Financial Year ended 31st March 2025 Appointment of Company Secretary and Compliance Officer (As Per BSE Announcement Dated on: 30.05.2025) | ||
| Board Meeting | 22 May 2025 | 22 May 2025 |
| Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. | ||
| Board Meeting | 24 Apr 2025 | 17 Apr 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2025 inter alia to consider and approve 1. To Approve the Letter of Offer (LOF) for the proposed Rights Issue of 491904000 Equity Shares of Re. 1/- each aggregating to 4919.04 lakhs for shareholders of the Company. 2. Any other item with the permission of the Chair and Majority of Directors. The Board of Directors of the Company at its meeting held today, i.e. April 24, 2025 have considered and approved inter alia the following: 1. The Letter of Offer, Abridged Letter of Offer, Rights Entitlement Letter, Application Form and other issue related terms and documents. The Letter of Offer to be filed with BSE Limited. 2. Rights Issue Period: ISSUE OPENING DATE APRIL 30, 2025 ISSUE CLOSING DATE May 14, 2025. (As Per BSE Announcement Dated on: 24/04/2025) | ||
| Board Meeting | 7 Apr 2025 | 1 Apr 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/04/2025 inter alia to consider and approve 1. To consider and approve the number of shares to be issued on a rights basis issue price rights entitlement ratio for the proposed Right Issue. 2. To fix Record Date to ascertain the eligible shareholders for the proposed Right Issue and other matters and terms and conditions incidental or connected therewith. 3. Any other item with the permission of the Chair and Majority of Directors. Board approved :- 1. Considered, approved and fixed Tuesday, 15 April, 2025 as the Record Date for the purpose of determining the equity shareholders entitled to receive rights entitlements in the Rights Issue; 2. Considered and approved the following terms of the right issue. a. Ratio: 61 (Sixty-One) Rights Equity Shares for every 50 (Fifty) Fully Paid Equity Shares held by the Existing Shareholders on the Record Date. Outcome of Board Meeting held on April 07, 2025 for 1)Considering approving and fixing Tuesday, 15 April, 2025 as the Record Date for the purpose of determining the equity shareholders entitled to receive rights entitlements in the Rights Issue; 2) Considering and approving the terms of the right issue (As Per BSE Announcement Dated on 07.04.2025) | ||
| Board Meeting | 14 Feb 2025 | 8 Feb 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 31st December 2024. 2) Any Other Business With The Permission Of The Chair. Outcome of Board Meeting held on Friday, February 14, 2025. (As Per Bse Announcement Dated on 14.02.2025) | ||
| Board Meeting | 25 Jan 2025 | 25 Jan 2025 |
| Outcome of Board Meeting for approval of Draft Letter of Offer in regards to the Rights Issue of Equity Shares. | ||
| Board Meeting | 22 Jan 2025 | 17 Jan 2025 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 inter alia to consider and approve raising funds by way of issue of fresh equity shares through Right Issue basis along-with other matter if any as may be permitted under applicable laws subject to such regulatory/statutory approvals as may be required. 2) Any other business with the permission of the Chair. Outcome of Board Meeting held on Wednesday, January 22, 2025 for 1) Right issue of shares 2) Increase in authorised share capital 3) Appointment of Additional Independent Director (As Per BSE Announcement dated on 22.01.2025) | ||
| Board Meeting | 14 Nov 2024 | 9 Nov 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Remedium Lifecare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter and Half Year Ended 30th September 2024.2) Any other business with the permission of the Chair Outcome of Board Meeting held on Thursday, November 14, 2024. (As per BSE Announcement Dated on 14/11/2024) | ||
| Board Meeting | 31 Oct 2024 | 31 Oct 2024 |
| In terms of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 read with Part A of Schedule III, We are pleased to inform you that the Board of Directors in their meeting held today on 31st October 2024 at the Registered Office of the Company at 1.00 P.M | ||
| Board Meeting | 4 Sep 2024 | 27 Aug 2024 |
| Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2024 inter alia to consider and approve 1. Acquisition of a company Airowater Global Trading LLC UAE which is into Water Injectables for Pharma Production. 2. Consideration of issuing of Foreign Currency Convertible Bonds (FCCBs) 3. Any other business with the permission of the Chair The Board Meeting to be held on 03/09/2024 has been revised to 04/09/2024 The Board Meeting to be held on 03/09/2024 has been revised to 04/09/2024 inter alia 1. To Consider Acquisition of AirOWater Global Trading LLC, UAE:The Board will review the proposal to acquire a substantial stake in AirOWater Global Trading LLC, a pioneering entity in the production of the purest form of drinking water via Atmospheric Water Generators (AWGs). This technology, recognised as one of the most sustainable solutions to the pressing issue of global water scarcity, has successfully catered to diverse sectors including Government Institutions, Corporates, Hospitality chains, Supermarkets, Hospital chains, Educational institutions, and Community Centres. 2. To Consider issuing of Foreign Currency Convertible Bonds (FCCBs). 3. Any other business with the permission of the Chair. (As per BSE Announcement Dated on 28/08/2024) Outcome of the Board Meeting held on 04th September, 2024 (As per BSE Announcement Dated on 04/09/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.